Market
FTC Approval of Major Biopharma Merger by End of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
FTC announcements and major news outlets
Story
FTC Blocks $25 Billion Kroger-Albertsons Merger; Trump Names New FTC Chair
Dec 11, 2024, 04:06 PM
A federal judge has blocked the $25 billion Kroger-Albertsons supermarket merger, citing concerns that the deal would have raised grocery prices, reduced competition, and harmed consumers and workers. The Federal Trade Commission (FTC), under the leadership of Lina Khan, played a pivotal role in challenging the merger, garnering praise from lawmakers and advocates for protecting consumer interests and promoting competition. The decision, which also involved efforts in King County, is seen as a significant victory for working families, small farmers, and communities concerned about consolidation in the food industry. The FTC's two-year effort to block the deal highlights its commitment to addressing anti-competitive practices. Meanwhile, President-elect Donald Trump has nominated Andrew Ferguson to replace Lina Khan as FTC chair. Ferguson's appointment is expected to bring a shift in FTC policy, potentially easing restrictions on mergers and acquisitions, including in sectors like biopharma and technology.
View original story
Similar markets
Yes • 50%
No • 50%
No action taken • 25%
Fines imposed • 25%
Policy changes mandated • 25%
Other outcomes • 25%
Yes • 50%
No • 50%
Eli Lilly • 25%
Pfizer • 25%
Other • 25%
GSK • 25%
Minor Misconduct Found • 25%
Significant Misconduct Found • 25%
Severe Misconduct Found • 25%
No Misconduct Found • 25%
No change • 25%
Other • 25%
Less aggressive • 25%
More aggressive • 25%
CVS Health’s Caremark • 33%
None • 1%
UnitedHealth’s OptumRx • 33%
Cigna’s Express Scripts • 33%
No significant changes • 25%
Other regulatory changes • 25%
Revised merger guidelines • 25%
New antitrust legislation • 25%